Ceftazidime
Back to searchMolecule Structure
Scientific Name
Ceftazidime
Description of the Drug
Ceftazidime is an injected broad-spectrum third-generation cephalosporin beta-lactam antibiotic used to treat or prevent a variety of bacterial infections, including pneumonia, gynecological infections, bone and joint infections, and septicemia, among others.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00438
http://www.drugbank.ca/drugs/DB00438
Brand Name(s)
Ceftazidime, Ceptaz, Fortam, Fortaz, Fortum, Kefazim, Pentacef, Tazicef, Tazidime
Company Owner(s)
Glaxosmithkline, Hospira Inc, Eli Lilly And Co, Pai Holdings Llc Dba Pharmaceutical Associates Inc, Aurobindo Pharma Ltd, Wockhardt Ltd, B Braun Medical Inc, Acs Dobfar Spa, Allergan Sales Llc, Baxter Healthcare Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial penicillin-binding protein | PROTEIN FAMILY | INHIBITOR | CHEMBL2354204 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL36849 | |||||
PharmGKB | PA448861 | |||||
Human Metabolome Database | HMDB0014582 | |||||
DrugBank | DB00438 | |||||
PubChem: Thomson Pharma | 14763620 | 14861453 | ||||
PubChem | 5481173 | 57514439 | 73415817 | |||
NMRShiftDB | 60027504 | |||||
BindingDB | 50420259 | |||||
EPA CompTox Dashboard | DTXSID5022770 | |||||
Brenda | 743 | 122922 | 37962 | |||
ChemicalBook | CB7289569 | |||||
Guide to Pharmacology | 10762 | |||||
rxnorm | FORTAZ | CEFTAZIDIME PENTAHYDRATE | CEFTAZIDIME ANHYDROUS | CEFTAZIDIME | CEFTAZIDIME SODIUM | TAZICEF |
KEGG Ligand | C06889 | |||||
ChEBI | 3508 |